169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
IDENTIFYING CORONARY OR SOFT TISSUE CALCIFICATION
#5702HUMAN VASCULAR IBP-LIKE GROWTH FACTOR
#5703COMPOSITIONS AND METHODS FOR THE INNATE IMMUNE RESPONSE PATHWAY
#5704Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides
#5705Protein Isoforms and Uses Thereof
#5706Cancer-associated antigen
#5707Diagnostic tests of substance use disorders
#5708Binder for C-reactive protein
#5709SCREENING METHOD TO IDENTIFY PROTECTIVE SUBSTANCES FOR THE TREATMENT OF NEURODEGENERATIVE AND/OR ISCHAEMIC DISEASES
#5710MICROBIAL MARKERS OF INFLAMMATORY BOWEL DISEASE
#5711METHODS FOR THE DIAGNOSIS OF PROLIFERATIVE AND/OR CONFORMATIONAL DISEASES
#5712MASTER GENE OF ARTERIOGENESIS
#5713R-RAS activity in vascular regulation
#5714CHIMERIC T CELL RECEPTORS AND RELATED MATERIALS AND METHODS OF USE
#5715Marker of wound infection
#5716METHODS FOR DIAGNOSING CHRONIC DIARRHEA THROUGH PROTEIN SECRETION ANALYSIS
#5717Predicting hemostatic risk; dependence on plasma composition
#5718Methods for identifying a GLP-1 secretagogue
#5719Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction
#5720Methods and kit for early detection of acute coronary syndrome and prediction of adverse cardiac events
#5721Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1)
#5722Diagnostic test for cardiomyopathy
#5723Biomarkers of ionizing radiation
#5724ASSAYS FOR MODULATORS OF ASPARAGINYL HYDROXYLASE
#5725Serum markers for type II diabetes mellitus
#5726Biomarkers for Niemann-pick C disease and related disorders
#5727Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm
#5728Methods for drug discovery, disease treatment, and diagnosis using metabolomics
#5729Biomarkers for assessing liver function
#5730Method for detecting lysosomal storage diseases
#5731METHODS OF DIAGNOSIS AND TREATMENT OF OSTEOPOROSIS
#5732Prion epitopes and methods of use thereof
#5733SERUM AMYLOID A PROTEIN IN INFLAMMATION AND OBESITY
#5734Use of A33 antigens and JAM-IT
#5735COMPOSITIONS AND METHODS FOR TREATING CARDIOVASCULAR DISEASE AND MYOCARDIAL INFARCTION WITH DIPEPTIDYL PEPTIDASE INHIBITORS OR B TYPE NATRIURETIC PEPTIDE ANALOGUES RESISTANT TO PROLYL-SPECIFIC DIPEPTIDYL DEGRADATION
#5736Method to measure serum biomarkers for the diagnosis of liver fibrosis
#5737Marker proteins for diagnosing liver disease and method of diagnosing liver disease using the same
#5738LEVELS OF BLyS/APRIL HETEROTRIMERS IN SERUM AND USE IN DIAGNOSTIC METHODS
#5739Diabetes-related biomarkers and methods of use thereof
#5740Assessing risk of disease progression in rheumatoid arthritis patients
#5741METHODS OF DETECTING AND TREATING MYOCARDIAL ISCHEMIA AND MYOCARDIAL INFARCTION
#5742EVALUATION OF EOSINOPHILIC ESOPHAGITIS
#5743DOT1 histone methyltransferases as a target for identifying therapeutic agents for leukemia
#5744PREDICTION OF AN INDIVIDUAL'S RISK OF DEVELOPING RHEUMATOID ARTHRITIS
#5745Predicting risk of major adverse cardiac events
#5746Novel assay for precursor T-cells having high proliferative capacity (PHPC-asay)
#5747Method for determining health status by analyzing analytes
#5748OSTEOPOROSIS ASSOCIATED MARKERS AND METHODS OF USE THEREOF
#5749Methods of identifying anti-inflammatory compounds
#5750IL-32B-TARGETED DIAGNOSIS AND THERAPY
#5751Compositions and Methods for Modulating mTOR Signaling
#5752Diagnostic and therapeutic uses of gelsolin in renal failure
#5753Investigation of mucosa dryness conditions
#5754Stress-induced phosphoprotein 1 as a biomarker for the detection of human ovarian cancers and endometriosis
#5755Method for diagnosing irritable bowel syndrome and monitoring inflammatory bowel disease
#5756Mutated ACVR1 for diagnosis and treatment of Fibrodyplasia Ossificans Progressiva (FOP)
#5757Differentially expressed tumour-specific polypeptides for use in the diagnosis and treatment of cancer
#5758Apparatus for body fluid analysis using surface-textured optical materials
#5759Treating diseases mediated by metalloprotease-shed proteins
#5760Method and apparatus for analyzing vitamin E in lipoproteins
#5761Use of MRP 8/14 levels for discrimination of individuals at risk of acute coronary syndromes
#5762Rapid test for glycated albumin in blood
#5763DIAGNOSTIC COMPOSITIONS AND TREATMENT METHODS FOR CONDITIONS INVOLVING TROPHOBLAST CELL DEATH, DIFFERENTIATION, INVASION AND/OR CELL FUSION AND TURNOVER
#5764NOVEL DRUG DISCOVERY TARGET AND MEDICINE ACTING ON THE SAME
#5765Methods for Inhibiting Amyloid Precursor Protein and Beta-Amyloid Production and Accumulation
#5766METHODS OF USING QUANTITATIVE LIPID METABOLOME DATA
#5767Methods of diagnosing acute cardiac disorders using BNP-SP
#5768Method for diagnosis and prognosis of epithelial cancers
#5769Method for the early identification and prediction of kidney injury
#5770Method for the identification of a risk for a thrombogenic disorder by determining the TAFI-lle347 polymorphism
#5771THERAPEUTIC AND DIAGNOSTIC AGENTS
#5772Method for the early indentification and prediction of an abrupt reduction in kidney function in a patient undergoing cardiothoracic surgery
#5773Osteogenic compositions comprising an amino acid sequence capable of being phosphorylated by CAMK2
#5774Use of outer membrane protein a in treatment/prevention/diagnosis of bacterial infection in central nervous system and/or peripheral blood circulation
#5775METHODS AND ASSAYS TO ASSESS CARDIAC RISK AND ISCHEMIA
#5776DIAGNOSTIC MARKER FOR ALLERGY
#5777Diagnosis of eosinophilic esophagitis based on presence of an elevated level of eotaxin-3
#5778Compositions and methods for the treatment of natural killer cell related diseases
#5779METHODS OF DETERMINING SKELETAL MATURITY
#5780Methods for the detection and monitoring of congestive heart failure
#5781Method to Diagnose or Screen for Inflammatory Diseases
#5782METHOD FOR MEASURING RESISTANCE OR SENSITIVITY TO DOCETAXEL
#5783AGENTS AND METHODS FOR DIAGNOSING OSTEOARTHRITIS
#5784Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses therefor
#5785and genes and uses thereof
#5786Diagnostics and Therapeutics For Glaucoma
#5787COMPOSITIONS AND METHODS FOR REDUCING THE LIKELIHOOD OF IMPLANTATION FAILURE OR MISCARRIAGE IN RECIPIENTS OF ARTIFICIAL INSEMINATION
#5788Increasing glucose transport and insulin-stimulated glucose uptake
#5789Method for modulating, treating and/or preventing metabolic syndrome using MAS-G-protein-coupled receptor agonists
#5790METABOLITE MARKERS FOR WEIGHT MANAGEMENT
#5791Distinction between bacterial meningitis and viral meningitis
#5792Diagnostic method for disorders using copeptin
#5793METHODS FOR DIAGNOSIS OF CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME
#5794ASSESSING NON-ALCOHOLIC FATTY LIVER DISEASE
#5795METHOD FOR DIAGNOSING HEPATIC DISEASES AND SCREENING METHOD OF MOLECULES FOR TREATMENT OF HEPATIC DISEASE
#5796PEPTIDES AGAINST AUTOANTIBODIES ASSOCIATED WITH GLAUCOMA AND USE OF THESE PEPTIDES
#5797METHODS TO IDENTIFY FAT AND LEAN ANIMALS USING CLASS PREDICTORS
#5798VIVIT POLYPEPTIDES, THERAPEUTIC AGENT COMPRISING THE SAME, AND METHOD OF SCREENING FOR ANTI-CANCER AGENT
#5799DIAGNOSIS AND MONITORING OF CHRONIC RENAL DISEASE USING NGAL
#5800METHODS FOR DIAGNOSIS OF ACUTE CORONARY SYNDROME
#5801Pancreatic polypeptide as target/marker of beta cell failure
#5802ATLASTIN
#5803MODULATION OF BNE DEVELOPMENT
#5804Human Marker Genes and Agents for Diagnosis, Treatment and Prophylaxis of Cardiovascular Disorders and Artherosclerosis
#5805Human monoclonal antibodies against Hendra and Nipah viruses
#5806Method of ameliorating symptom caused by mood disturbance
#5807Biomarkers and assays for myocardial infarction
#5808Method and kit for diagnosing acute myocardial infarction
#5809Insulin promoter factor 1 as target/marker of beta cell failure
#5810Method for diagnosis and/or prognosis of a septic syndrome
#5811Diagnosis of liver pathology through assessment of protein glycosylation
#5812Diagnostic And Therapeutic Uses Of Augmenter Of Liver Regeneration In Inflammatory Conditions
#5813Methods for identifying insulin mimetics
#5814Soluble CD14 antigen
#5815Detection of specific nitrated markers
#5816Modulation of Peripheral Clocks in Adipose Tissue
#5817AGENTS FOR IMPROVING CHRONIC OBSTRUCTIVE PULMONARY DISEASES
#5818ALTERED SUMOYLATION OF LAMIN A PROTEIN ASSOCIATED WITH DILATED CARDIOMYOPATHY
#5819Hypercholestrolemia and tendinous injuries
#5820METHOD FOR THE PREDICTION OF VASCULAR EVENTS AND THE DIAGNOSIS OF ACUTE CORONARY SYNDROME
#5821Marker for inflammatory conditions
#5822SYSTEMS AND METHODS FOR CHARACTERIZING KIDNEY DISEASE
#5823METHODS FOR DIAGNOSIS AND TREATMENT OF CHRONIC IMMUNE DISEASES
#5824Methods and Devices for Rapid Assessment of Severity of Injury
#5825Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems
#5826Methods for diagnosis of cardiovascular disease
#5827Methods, products and treatments for diabetes
#5828Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease
#5829NOVEL PEPTIDES FOR TREATING AND PREVENTING IMMUNE-RELATED DISORDERS, INCLUDING TREATING AND PREVENTING INFECTION BY MODULATING INNATE IMMUNITY
#5830Method for determination of inflammatory bowel disease
#5831Type IV collagen-like immunoreactive peptide
#5832Anti-αβantibodies
#5833Bio-Markers For Diagnosing Diabetic Retinopathy
#5834Manufacture of active highly phosphorylated human lysosomal sulfatase enzymes and uses thereof
#5835METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#5836Methods for treating cardiac disease by modifying an N-terminal domain of troponin I
#5837Marker for Chromosomal Abnormalities
#5838METHODS FOR TREATING MITF-RELATED DISORDERS
#5839TISSUE REJECTION
#5840In vitro method for the detection of early-stage liver damage
#5841Method for detecting cardiac collateral formation
#5842METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF CROHN'S DISEASE
#5843Nucleic acid encoding monkey QRFP
#5844NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSIS
#5845METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MALARIA
#5846NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF IMMUNE RELATED DISEASES
#5847NOVEL USE OF G-PROTEIN-CONJUGATED RECEPTOR AND LIGAND THEREOF
#5848Peptide for inhibition of calcineurin, nucleic acid, antibody, and diagnostic and therapeutic methods of use
#5849Determination of Neutrophil Gelatinase-Associated Lipocalin (NGAL) as a Diagnostic Marker for Renal Disorders
#5850Screening compounds for activity in modulating chloride ion transport
#5851Prostasin partial peptide and anti-prostasin antibody
#5852Crohn's disease antibody epitope peptide and reagent for testing Crohn's disease
#5853IDENTIFYING THERAPEUTIC COMPOUNDS BASED ON THEIR PHYSICAL-CHEMICAL PROPERTIES
#5854IDENTIFYING THERAPEUTIC COMPOUNDS BASED ON THEIR PHYSICAL-CHEMICAL PROPERTIES
#5855Competitive receptor binding assay for detecting beta-glucans
#5856Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof
#5857COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING ASTHMA OR OTHER ALLERGIC OR INFLAMMATORY DISEASES
#5858Gene defects and mutant ALK kinase in human solid tumors
#5859Biological markers for longevity and diseases and uses thereof
#5860PIGF and FLT-1 as Prognostic Parameters for Cardiovascular Diseases
#5861Method for determining insulin sensitivity with biomarkers
#5862Methods and devices for diagnosis of appendicitis
#5863TLE3 as a marker for chemotherapy
#5864MARKER FOR CANCER PROGNOSIS AND METHODS RELATED THERETO
#5865Genes from the 20q13 amplicon and their uses
#5866Novel composition and methods for the treatment of psoriasis
#5867Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
#5868Compositions and methods for treatment of diabetic retinopathy
#5869Thyroglobulin quantitation by mass spectrometry
#5870Antibodies and Improved Test Sample Handling Methods for Use in Assays for Myeloperoxidase
#5871Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (MRP-1) and their use in diagnostic and therapeutic applications
#5872Method of diagnosing the presence and/or severity of a hepatic pathology in an individual and/or of monitoring the effectiveness of a treatment for one such pathology
#5873Detection of Inducible Resistance to Macrolide-Lincosamide-Streptogramin b
#5874Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#5875METHOD FOR THE EARLY DETECTION OF RENAL INJURY
#5876Novel Gene Disruptions, Compositions and Methods Relating Thereto
#5877Anti-VEGF antibodies
#5878Methods of diagnosis and treatment of metabolic disorders
#5879Single nucleotide polymorphisms sensitively predicting adverse drug reactions (ADR) and drug efficacy
#5880Vascular Aging-Predicting Factor and Utilization of the Same
#5881Determination of short-chain SRL alcohol dehydrogenase (DHRS4) as a biomarker for inflammations and infections
#5882Lipoprotein Associated Phospholipase A2, Inhibitors Thereof and Use of the Same in Diagnosis and Therapy
#5883Diagnosis and treatment of type 2 diabetes and other disorders
#5884Methods for producing an immune response to tuberculosis
#5885MODULATORS OF ODORANT RECEPTORS
#5886Modulators of odorant receptors
#5887Method Of Diagnosing A Body Weight Condition Or Predisposition
#5888IMMUNOASSAYS AND KITS FOR THE DETECTION OF NGAL
#5889METHOD AND KIT FOR DETECTING THE EARLY ONSET OF RENAL TUBULAR CELL INJURY
#5890MOLECULES INVOLVED IN SYNAPTOGENESIS AND USES THEREFOR
#5891CCR3 inhibition for ocular angiogenesis and macular degeneration
#5892Measurement of melanocortin peptides and uses thereof
#5893Anti-Antiogenic Fragments of Pigment Epithelium-Derived Factor (PEDF)
#5894Method for measuring human megalin
#5895SYSTEMS AND METHODS FOR ANALYZING PERSISTENT HOMEOSTATIC PERTURBATIONS
#5896Kits for the diagnosis of pre-eclampsia or eclampsia
#5897Method for identifying type I diabetes mellitus in humans
#5898Methods of determining allergen response using microarray immunoassay techniques
#5899Methods for differentiation between cardiac and pulmonary causes of chronic dyspnea
#5900Simultaneous detection of metabolic enzyme activity and metabolite levels
#5901Method of detecting protein losing enteropathy in animals
#5902Method of determining pregnancy toxemia
#5903Method of classifying human subjects having adolescent idiopathic scoliosis
#5904Methods for detecting inflammatory bowel disease
#5905Ascorbic acid conjugates
#5906MARKERS FOR PREECLAMPSIA
#5907Compositions for controlling hair growth
#5908Noninvasive measurement and identification of biomarkers in disease state
#5909Treatment of atherosclerosis
#5910House Dust Mite Allergen
#5911Methods of Identifying and Treating Individuals Exhibiting MDR-1 Overexpression With Protein Tyrosine Kinase Inhibitors and Combinations Thereof
#5912TREATMENT OF DNA DAMAGE RELATED DISORDERS
#5913Methods of detecting early renal disease in animals
#5914ALPK1 GENE VARIANTS IN DIAGNOSIS RISK OF GOUT
#5915DIAGNOSTICS AND THERAPEUTICS FOR RESTENOSIS
#5916Glycated peptides and methods of use
#5917Method of Detecting Kidney Dysfunction
#5918Core 2 β(1,6)-acetylglycosaminyltransferase as diagnostic marker for atherosclerosis
#5919PROTEIN-BASED BIOMARKERS FOR ABDOMINAL AORTIC ANEURYSM
#5920Modulators that promote cell surface expression of odorant receptors
#5921PEPTIDE-BASED IMMUNIZATION THERAPY FOR TREATMENT OF ATHEROSCLEROSIS
#592244 Human Secreted Proteins
#5923Serum biomarkers for early detection of acute cellular rejection
#5924Diagnosis, prevention and treatment of cancer
#5925COMPOSITIONS AND METHODS FOR TREATING DISEASES
#5926Biochemical markers for acute pulmonary embolism
#5927Assays
#5928Peptide biomarkers predictive of renal function decline and kidney disease
#5929METHOD FOR DETECTING DEEP VENOUS THROMBOSIS
#5930DISCRIMINATON OF CARDIAC DYSFUNCTION IN PREGNANT FEMALES
#5931ANTI-PRO87299 ANTIBODIES
#5932Method for reducing the likelihood of implantation failure during assisted reproduction in a subject
#5933AGENT FOR PROPHYLAXIS AND TREATMENT OF PANCREATITIS
#5934Methods of treatment of renal disease
#5935Immunochemical determination method and determination reagent for cytochrome c
#5936Use of haptoglobin genotyping in diagnosis and treatment of defective reverse cholesterol transport (RCT)
#5937Peptide for diagnosing, preventing and treating atherosclerosis and uses thereof
#5938COMPOSITIONS AND METHODS FOR TREATING DIABETIC EYE DISEASE
#5939METHOD OF IDENTIFYING PROTEINS IN HUMAN SERUM INDICATIVE OF PATHOLOGIES OF HUMAN LUNG TISSUES
#5940Endothelial-monocyte activating polypeptide II, a biomarker for use in diagnosis of brain injury
#5941MARKERS FOR PREECLAMPSIA
#5942Biomarker for diagnosing heart disease and the use thereof
#5943Diagnostic methods for congestive heart failure
#5944Methods of diagnosing osteoarthritis
#5945Substrates and internal standards for mass spectrometry detection
#5946METHODS AND COMPOSITIONS FOR DIAGNOSIS AND IMMUNOTHERAPY OF POLLEN ALLERGY
#5947Stationary Phase Antibody Arrays for Trace Protein Analysis
#5948Assessing the risk of a major adverse cardiac event in patients with chest pain
#5949Methods and Compositions for Measuring Canine BNP and Uses Thereof
#5950COMPOSITION FOR ANALYZING DIABETES MELLITUS AND/OR RETINAL VASCULAR DISEASE AND ANALYZING METHOD THEREOF
#5951P-Selectin associated with Eosinophils as a marker for asthma and correlating with B-1 integrin activation
#5952Phosphorylated or Non-Phosphorylated MPR as Diagnostic Marker or Therapeutic Target
#5953Rage Fusion Proteins and Methods of Use
#5954Proteomic analysis of biological fluids
#5955Device and method of monitoring a patient
#5956Modulators of Retinol-Retinol Binding Protein (RBP)-Transthyretin (TTR) Complex Formation
#5957Methods of diagnosing leiomyoma by measuring catechol-O-methyltransferase
#5958Molecules involved in regulation of osteoblast activity and osteoclast activity, and methods of use thereof
#5959METHOD OF TREATING STRESS-MEDIATED DEPRESSION
#5960Materials and methods for the detection of nitrated fibrinogen
#5961Natriuretic peptides and placenta growth factor levels for risk stratification
#5962ULTRAHIGHLY SENSITIVE DETERMINATION REAGENT FOR C-REACTIVE PROTEIN AND DETERMINATION METHOD
#5963Use of the AXL receptor for diagnosis and treatment of renal disease
#5964Synthetic ligands for the differentiation of closely related toxins and pathogens
#5965T cell receptors and related materials and methods of use
#5966METHOD OF DETECTING MILD IMPAIRED GLUCOSE TOLERANCE OR INSULIN SECRETORY DEFECT
#5967NT-proANP and NT-proBNP for diagnosing cardiac diseases
#5968BETA2-microglobulin and C reactive protein (CRP) as biomarkers for peripheral artery disease
#5969Assays for erectile and bladder dysfunction and vascular health
#5970CAP/SORBS1 AND DIABETES
#5971Method for reducing the likelihood of spontaneous abortion presenting a sign or symptom of threatened abortion
#5972COMPOSITIONS AND METHODS FOR HEALTHY PREGNANCY
#5973Method for determination of oxidative stress
#5974Modulation of aqueous humor outflow by targeting vascular-endothelial-cadherin in Schlemm's canal cells
#5975RAPID DIAGNOSTIC METHOD FOR DISTINGUISHING ALLERGIES AND INFECTIONS AND NASAL SECRETION COLLECTION UNIT
#5976Method for reducing the likelihood of implantation failure during an assisted reproduction in a subject in need thereof
#5977Methods for detecting and treating interstitial cystitis
#5978Cardiac hormones for assessing cardiovascular risk
#5979Method for discriminating between prostatic cancer and benign prostatic hyperplasia
#5980High throughput sarcomeric assay
#5981Method of screening placental proteins responsible for pathophysiology of preeclampsia, and marker for early diagnosis and prediction of preeclampsia
#5982Reagent and kit for early diagnosis of kidney disease
#5983Attractin/mahogany-like polypeptides
#5984Anti-PRO87299 antibodies
#5985METHODS FOR DRUG DISCOVERY, DISEASE TREATMENT, AND DIAGNOSIS USING METABOLOMICS
#5986Diabetes-related biomarkers and methods of use thereof
#5987A Method of Treating Cancer
#5988Polypeptide complex that regulates cell cycle and anergy
#5989Use of calmodulin kinase II inhibitors to treat myocardial dysfunction in structural heart disease
#5990Receptor Tyrosine Kinase Signaling Pathway Analysis For Diagnosis And Therapy
#5991Diagnosis of Sepsis by the Selective Determination of the Concentration of Cu/Zn Superoxide Dismutase (Cu/Zn Sod) in Patient Samples
#5992SUSCEPTIBILITY TO BONE DAMAGE
#5993Connective Tissue Growth Factor-4
#5994Animal Model for Assessing Copd-Related Diseases
#5995PDE11A mutations in adrenal disease
#5996METHODS AND COMPOSITIONS FOR DIAGNOSIS AND/OR PROGNOSIS IN SYSTEMIC INFLAMMATORY RESPONSE SYNDROMES
#5997Method of Diagnosing Cerebral Infarction
#5998Method for Determining Condition of Disseminated Intravascular Coagulation
#5999Methods of diagnosing pre-eclampsia or eclampsia
#6000Real-Time Assays Of Neuro-Humoral Factors To Assess Cardiovascular Stress